Fifteen years have passed since the foundation of Farma.Invest, a holding company for equity investments in pharmacies, and in these years, although the entry of capital into pharmacies took place in 2017, Farma.invest has positioned itself as the only entity capable of covering the entire pharmacy chain, investing across the board in all sectors of the healthcare world.
Twenty companies controlled by the holding company have created an ecosystem where pharmacies and operators in the sector find in Farma.Invest a reliable player to express potential and commercial development. An ecosystem that has developed year after year: Farma.invest, which was created to shorten the chain of services in pharmacies, has immediately aroused great interest, reaching over one hundred pharmacist members in a very short time.
With such a large membership and sector, Farma.Invest is increasing its investments by covering the entire service chain and entering the commercial and industrial sectors with the storage site and the production of supplements.
With the Crescitalia decree of 2017, Farma.Invest made a further development: it doubled its capital, making it ready for investments in shareholdings in pharmacies. To date, it holds 20 pharmacies in Campania and Puglia.
Proprietary pharmacies, distribution, medical devices, pharmacy furnishings, services, real estate and environment: this is the complex Farma.Invest galaxy that President Michele Falco tries to illustrate: “We are organised into four specific divisions, each administered by experts in the sector. The pharmacy division has 20 locations and we plan to grow by two locations per year. The distribution division is fully covered with Mizar and Pharmalub in intermediate and Itaste medical group in medical device. With the environment division we cover the entire supply chain from pharmacy accounting, collection to transport to our authorised storage site. A complex world also in the light of new regulations. The services division includes a wide bouquet of holdings: insurance, inventories, HACCP and occupational safety, pharmacy furniture and real estate. Everything that pharmacies need”.
Farma.Invest, besides being unique in the pharmacy sector, is an excellent financial investment as Managing Director Mario Muzio explains: “Over the last 5 years we have distributed 6 million in dividends with an average roe of around 7%. We have a net worth of 18 million, underestimated by having undervalued goodwill and an ebitda of 3 million. Those who invest in Farma.Invest have a low risk profile as all our holdings are in the healthcare sector. Portfolio excellence and diversification guarantee steady profits. A stable majority and governance entrusted to professionals in the sector allow us to achieve the goals of the business plan, which sees revenues approaching 60 million this year”.
The managing director concludes by outlining the future: a new capital increase for the entry of 50 new shareholders, two acquisitions per year, a club deal for joint pharmacy acquisitions. Furthermore, Farma.Invest has reached the maturity to think about something structured such as the entry of a fund or an investment bank.
Farma.Invest, innovation and investment for the future of pharmacy.
